Search Bar & Filters
Found 5 Actively Recruiting clinical trials
Actively Recruiting
Healthy Volunteer
Researchers are evaluating the effects of different prebiotic products on adults experiencing feelings of anxiety. This randomized, double-blind, placebo-controlled study aims to determine whether these products influence anxiety levels and related wellness outcomes compared with a placebo. The study is conducted in two waves under a unified protocol to ensure scientific independence while sharing infrastructure for safety and data management. Participants will be randomly assigned to receive either one of two active prebiotic products or a placebo. They will consume a daily oral powder sachet with food or beverage for 12 weeks, followed by a 4-week washout period. The study includes multi-omic biospecimen collections, such as stool and blood samples at several timepoints, and digital monitoring through wearable devices and smartphone-based assessments. During the 17-week study, participants complete baseline health assessments and regular evaluations to track feelings of anxiety, sleep quality, stress, depression, and other health markers. Biological samples and digital data are collected remotely to analyze changes over time. Safety and adherence are monitored throughout, with participants unaware of their treatment assignment until the study ends.
Actively Recruiting
Researchers are evaluating whether using the HAPPI software can improve how pharmacists provide birth control services and how easily patients can access these services. This trial focuses on comparing pharmacist implementation and patient access with and without the HAPPI software to see if it offers improvements. The study involves 15 community pharmacies that will first continue their usual birth control services for several months without the software. Then, the HAPPI software will be introduced to replace previous paper or electronic processes as pharmacists continue providing birth control services. Outcomes during the control and intervention periods will be compared. Participants include pharmacists who provide birth control services and patients who receive these services at participating pharmacies. Researchers will measure aspects such as the number of pharmacists and pharmacy staff involved, payment methods like cash or insurance billing, and overall access to care during the study period of up to 5 months. The study is sponsored by EMPOWERX INC and runs through August 2026.
Actively Recruiting
Healthy Volunteer
This trial evaluates the use of the PEPPI software to improve pharmacist-provided HIV prevention services, specifically post-exposure prophylaxis PEP and pre-exposure prophylaxis PrEP. It aims to find out if the software can make it easier for pharmacists to deliver these services and for patients to access them. The study compares service delivery and patient access with and without the software in community pharmacies. The study involves 10 community pharmacies that first provide PEPPrEP services as usual control period. Then, the pharmacies introduce the PEPPI software in two phases the initial minimally viable product MVP version followed by an enhanced version. Pharmacists use the software to replace previous paper or electronic processes for providing PEPPrEP services during the intervention periods. Participants include pharmacists who provide PEPPrEP services using the software and patients who receive these services at participating pharmacies. Researchers measure outcomes related to service implementation such as number of pharmacists and staff involved, payment methods like cash or insurance billing, and implementation outcomes up to 12 months. They also assess patient access to care during this time. The study runs from August 2026 to September 2028.
Actively Recruiting
Healthy Volunteer
Researchers are conducting a randomized, double-blind, placebo-controlled study to evaluate the impact of health and wellness products on gastrointestinal-related quality of life and related health outcomes. The study focuses on adults in the United States who experience persistent digestive symptoms such as gas, bloating, indigestion, or irregular bowel movements for three months or more and aims to assess meaningful improvement in these symptoms. Participants will be randomly assigned to use either an active gastrointestinal health product or a placebo control product, both dietary supplements, for a period of 8 weeks. The study is fully remote, with no in-person visits, and participants will not know which product they are taking until the end of the trial. All data collection and assessments are done electronically over a 9-week period, including the 8 weeks of product use. During the study, participants will report their health indicators electronically at enrollment and regularly throughout the active product period. Key outcomes measured include changes in gastrointestinal quality of life, gas and bloating, fatigue, and feelings of anxiety over the 9-week study duration. The study monitors participant safety through self-reported data, with no in-person assessments or physical procedures involved.
Actively Recruiting
Healthy Volunteer
Researchers are evaluating the effects of health and wellness products on constipation and related symptoms in adults living in the United States through a randomized, double-blind, placebo-controlled study. The study aims to understand potential improvements in constipation and other gastrointestinal health outcomes over a 5-week period, with participants unaware of their assigned product until the study concludes. Participants will be randomly assigned to receive either an active gastrointestinal health product or a placebo dietary supplement, used as directed for four weeks. This direct-to-consumer study is conducted entirely electronically, with no in-person visits, allowing participants to report their health status remotely throughout the active treatment period. During the study, participants will submit self-reported data on constipation, gas and bloating, gastrointestinal symptom severity, and quality of life related to digestive health. Data collection occurs at enrollment and throughout the 5-week study duration using electronic methods. The study monitors changes in constipation as the primary outcome and assesses other gastrointestinal symptoms as secondary outcomes.